Differences in Blood and Cerebrospinal Fluid Between Parkinson's Disease and Related Diseases.
Ontology highlight
ABSTRACT: It is difficult to distinguish Parkinson's disease (PD) in the early stage from those of various disorders including atypical Parkinson's syndrome (APS), vascular parkinsonism (VP), and even essential tremor (ET), because of the overlap of symptoms. Other, more challenging problems will arise when Parkinson's disease develops into Parkinson's disease dementia (PDD) in the middle and late stages. At this time, the differential diagnosis of PDD and DLB becomes thorny. These complicate the diagnostic process for PD, which traditionally heavily relies on symptomatic assessment and treatment response. Recent advances have identified several biomarkers in the blood and cerebrospinal fluid (CSF), including α-synuclein, lysosomal enzymes, fatty acid-binding proteins, and neurofilament light chain,
SUBMITTER: Ma J
PROVIDER: S-EPMC11680620 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA